BlinkLab is trading 5.52% up at A$0.86 after closing at A$0.81 on August 19, 2026, with no new company-specific announcement identified to explain the August 20 move.
- The latest material update remains the positive European ADHD study.
- The study reported 82% sensitivity and 83% specificity and was announced on August 5.
- Healthcare-sector strength may provide background support, though the connection is unconfirmed.